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The mechanism of influenza hemagglutinin (HA) mediated membrane fusion has been intensively studied for over 20 years after the
bromelain-released ectodomain of HA at neutral pH was first crystallized. Nearly 10 years ago, the low-pH-induced ‘‘spring coiled’’
conformational change of HA was predicted from peptide chemistry and confirmed by crystallography. Other work has yielded a wealth of
knowledge on the observed changes in HA fusion/hemifusion phenotypes as a function of site-specific mutations of HA, or added
amphipathic molecules or particular IgGs. It is becoming clear that the conformational changes predicted by the crystallography are necessary
to cause fusion and that interfering with these changes can block fusion or reduce it to hemifusion. What is not known is how the
conformational changes cause fusion. In particular, while it is generally agreed that fusion requires an aggregate of HAs, how the aggregate
may act to transduce the energy of the HA conformational changes to creating the initial fusion defect is not known. We have used a
comprehensive mass action kinetic model of HA-mediated fusion to carry out a ‘‘meta-analysis’’ of several key data sets, using HA-
expressing cells and using virions. The consensus result of these detailed kinetic studies was that the fusion site of influenza hemagglutinin
(HA) is an aggregate with at least eight HAs. The high-energy conformational change of only two of these HAs within the aggregate permits
the formation of the first fusion pore. This ‘‘8 and 2’’ result was required to best fit all the data. We review these studies and how this kinetic
result can guide and constrain HA fusion models. The kinetic analysis suggests that the sequence of fusion intermediates starts with protein
control and ends with lipid control, which makes sense. While curvature intermediates, e.g. the lipid stalk, are almost certainly within the
fusion sequence, the ‘‘8 and 2’’ result does not suggest that they are the first step after HA aggregation. The stabilized hydrophobic defect
model we have proposed as a precursor to the lipid stalk can form and is consistent with the ‘‘8 and 2’’ result.D 2003 Elsevier B.V. All rights reserved.Keywords: Enveloped virus; Membrane protein aggregation; Hydrophobic1. Introduction
It is generally believed that the energy released by the
essential conformational changes of membrane fusion pro-
teins are required to stabilize the defects that lead from two
stable bilayers to the single bilayer of the fusion product
[1,2]. While it is generally agreed that fusion proceeds from
an HA aggregate [73,74,76,77], it is conjectured that lipid
mixing is initiated either by a high curvature bending defect
directly contacting the target bilayer [3–7] or a hydrophobic
defect in the viral bilayer forming a target for lipid perme-
ation from the target bilayer [8,9]. These two hypotheses
agree on most points, including the necessity of lipidic stalks
as one of the intermediates of fusion, whose formation0005-2736/03/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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steps to the lipid-controlled steps of fusion. The hypotheses
differ on the direct target of the transduced energy of the
protein’s conformational changes, which is the site of evo-
lutionary pressure on the conformational change in the first
place. So, it is actually important to know the first step of
destabilization. Unfortunately, despite the seeming differ-
ence in these two proposed mechanisms, no clear experiment
has favored one over the other, largely because both posit at
least two HA conformational changes. Furthermore, little is
known about the energetics of a membrane fusion site, which
is composed of a handful of HAs, some glycoprotein or
ganglioside receptors, a hundred or so lipids and water. All
the physical theories being used to model the site either
neglect the proteins, due to computational constraints, or are
being pushed beyond safe limits.
A fusion site is the first one of the HA aggregates to
succeed in forming a fusion pore. These HA aggregates
form rapidly subsequent to acidification [10]. Perhaps they
are preformed on the virion due to close packing. HA
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with fusion kinetics. However, the necessity of aggregation
and estimates for the numbers of HAs in the aggregates has
been inferred with increasing precision by kinetic studies
[10,12–14,73]. In order to initiate first fusion pore forma-
tion, there must be at least eight HAs in the aggregate [10].
The next question is what makes the HAs aggregate and
how does the aggregate form the first fusion pore?
There is a wealth of knowledge on the observed changes
in fusion/hemifusion phenotypes as a function of site-
specific mutations of HA, or added amphipathic molecules
or particular IgGs [3,5,7,15–20,78,80]. The conclusions of
these studies focus on the implied effect of the individual
HA. The explicit or implicit assumption is that all HAs
behave identically, i.e. all HAs within a particular fusion site
have synchronized conformational changes. However, each
HA can have one or more of at least four jobs with respect
to the overall fusion process: binding to target membrane
sialates, mediating self-aggregation, creating the initial bi-
layer defect, and allowing closer apposition of the bilayers
so that bilayer merger can commence. The transmembrane
domains appear to have a direct effect on this last job
[5,8,18]. If each HA performs all jobs synchronously, within
each HA aggregate, it would be difficult to determine how
each job is affected by the mutation or additive? While
cooperativity in the HA conformational changes appears to
occur [21,38], the fusion kinetics are most simply modeled
with a fusion site composed of HAs in different conforma-
tional states.
We approached this problem from the perspective of a
protein folding landscape, wherein the HAs within the
fusion site could be in different conformations and per-
haps performing different jobs. Our kinetic model was
constructed to have the data determine the answer. Fur-
thermore, data was fitted exhaustively, so that all possible
parameter sets that yielded best fits to the data were
found. This meta-analysis of several key data sets on
HA fusion, from different labs, showed that of the eight or
more HAs comprising a fusion site, only two undergo the
essential conformational changes needed for the first
fusion pore to form [10,21,22]. Only two of the eight
must do the ‘‘heavy lifting’’ to transduce their released
energy to stabilizing the initial defect of fusion. The
mechanism of initial lipid destabilization is unresolved,
but the kinetic analysis has given the same ‘‘8 and 2’’
result for several different experimental systems, including
intact virions. This result provides a new context within
which to understand the effect of mutations on HA-
mediated fusion.2. The mass action kinetics of HA-mediated membrane
fusion
Bentz [10] began the development of a comprehensive
mass action model for HA-mediated fusion based on thefusion intermediates listed above and used it to analyze the
electrophysiological data of Melikyan et al. [23] for first
fusion pore formation between HA-expressing cells and
ganglioside-containing planar bilayers. This data is the most
rigorous for fusion and the basic ‘‘8 and 2’’ result was clear
from its analysis. The model was extended in Mittal and
Bentz [22] to extract consensus kinetic parameters for the
data of Melikyan et al. [23], Danieli et al. [13] and
Blumenthal et al. [14] for HA-expressing cells fusing with
various target membranes. This required the explicit con-
sideration of what jobs the HAs bound to sialates on
glycophorin could accomplish. In Mittal et al. [21], proton-
ation and inactivation of HAs was added to the model to
analyze the data of influenza virions fusing with ganglio-
side-containing liposomes [24,25,72] and HA-expressing
cells fusing with RBCs [19,26]. The key architectural results
obtained first from HA-expressing cells, which have the
problem of a distribution of HA cell surface densities,
worked for the influenza virus fusing with target mem-
branes, where the HA surface density is essentially uniform
[27,28]. While rate constants varied, and the consensus-
fitted parameters from these studies will be shown below,
the ‘‘8 and 2’’ result holds for both virions and HA-
expressing cells.
2.1. The division of labor for fusion: the minimal aggregate
size and the minimal fusion unit
The mass action kinetic model includes only those steps
that are generally accepted as essential, plus a rigorous
distinction between the minimum number of HA trimers
aggregated at the nascent fusion site (which is denoted N)
and how many of those trimers that must undergo a slow
essential conformational change before the first conductivity
can be measured across the fusing systems (which is called
the minimal fusion unit and is denoted q). This ‘‘division of
labor’’ was required to fit the kinetics of first fusion pore
formation [10,23], which is the first measurable step of
fusion and is therefore the most rigorous measurement.
This distinction allowed us to show that HAs bound to
sialates on glycophorin could be members of the fusogenic
aggregate, but not undergo the essential conformational
change needed to form the first fusion pore [22]. This
analysis resolved a long-standing question. Influenza HA
contains both binding and fusion functions, and there was
controversy about whether the same HA can execute both
functions [12,19,29,30–32,79]. Ellens et al. [12] found that
glycophorin-bearing liposomes bound equally well to both
GP4f and HAb2 cells, implying the same number of HA-
sialate contacts, but fused much more with the HAb2 cells.
This proved that HAs need not be bound to sialate to induce
fusion and suggested that a particular HA might not be able
to perform both functions. Alford et al. [30] found that
influenza virions fused more slowly as the ganglioside
surface density in the target liposomes was increased above
10 mol%, suggesting that HA bound to ganglioside lost the
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found that detergent reconstituted virosomes could fuse with
liposomes conjugated with Fab’ fragments directed against
HA1 at or near the site of sialate binding. Simply being
bound to a large membrane-bound molecule did not stop
HA from eventually mediating fusion.
However, it is not known how well these Fab’ fragments
mimic sialate binding. The IgG’s used to generate the Fab’
fragments used in Millar et al. [32] were screened to not
inhibit the major conformational change of HA. Leikina et
al. [19] found that soluble sialates slow the major confor-
mational change of HA (X31 strain) and that RBC bound to
HA(X31)-expressing cells fused faster following a neur-
aminidase treatment, i.e. with a reduction in HA-sialate
contacts. The structural basis for sialate inhibition of the
low-pH conformational change of HA is unknown at this
time.
While the HAs bound to sialate on glycophorin may be
part of the fusogenic aggregate (see below ‘‘The mass action
model’’), our analysis showed that two HAs within the
fusogenic aggregate were unbound. It is not proven, but
seems safe to assume, that this pair is the same as the two
which undergo the essential conformational change needed
to create the fusogenic defect in a timely fashion [22]. This
suggested that the relatively weak HA-sialate binding con-
stant could not evolve to a higher affinity, as that would
inhibit HAs ability to mediate fusion. For fusion of the cells
with ganglioside planar bilayers, calculations suggested that
on average fewer than one of the HAs within the fusogenic
aggregate are bound. This implied that HA binding to
sialates is not necessary for fusion (see also Ref. [33]). It
also implied that the binding constant of HA to ganglioside
in a planar bilayer is at least 2–3 orders of magnitude
smaller than that to glycophorin on RBC. This could be due
to the difficulty for the HA1 binding site to reach sialates
right next to the bilayer. This prediction can be tested. This
is an example of the division of labor in fusion, i.e. there are
two jobs for HAs within the fusion site and sialate bound
HAs can fulfil only one of these jobs.
2.2. The mass action model
The current version of our mass action kinetic model of
HA mediated fusion is shown in Fig. 1 [21]. It has been built
through the post mortum analysis of data from several labs,
which guarantees that the model is not too finicky and is
focused on fitting only the most robust parameters. It is well
known that PR8, X31 and (at high surface densities) Japan
strains of the influenza virus hemagglutinin show inactiva-
tion of fusion capacity when the pH is low enough [21,34–
38]. The mechanism of this inactivation is not known, but in
order to obtain reliable rate constants for fusion for these
HAs, we must take this inactivation into account. The data
of Korte et al. [36,37] suggested that in addition to the
protonation required for activation of HA, the protonation of
a second site is required to allow HA inactivation of the PR8and X31 strains. Obviously, there might be more than a
single site on each HA monomer that must be protonated to
initiate the conformational changes leading to fusion, just as
more than one site might need to be protonated to initiate
those conformational changes leading to HA inactivation. In
step 1 of Fig. 1, we have considered only the sites with the
smallest pKs, i.e. the last sites to be protonated as the pH is
lowered. Since HA is a homotrimer, we do assume three
identical and independent protonation sites per HA, regard-
less of function. These protonation reactions are assumed to
occur instantaneously, relative to the protein conformational
changes, and remain at equilibrium throughout the fusion
process. Both of these assumptions are reasonable. The
equations governing these equilibrium reactions are shown
in Ref. [21].
We start with native HA at neutral pH (Fig. 1), denoted
HAna, which is first protonated to the fusion active form
with the fusion peptide exposed, denoted HAfp. If the pH is
low enough, HA is protonated further to an inactivatible
form, denoted HAfi. Whether inactivatible HA does in fact
inactivate will depend upon the pathway it follows, i.e. the
relative rate constants. Both HAfp and HAfi can move to the
next stage, wherein the fusion peptide is embedded into the
proper membrane to initiate fusion, denoted HAem. Whether
that membrane is the viral membrane or the target mem-
brane has been widely discussed, but is not germane to the
kinetic model. This will be discussed further below.
Inactivation is any conformational modification of HA
after protonation that renders it nonfusogenic, denoted by
HAin. Therefore, in step 1 of Fig. 1, we assume that both
species HAfp and HAfi can inactivate at different rates.
While not necessary for our kinetic analysis, it seems
simplest to consider inactivation to be the fate of an HA
that undergoes the essential conformational change, either in
the absence of target membrane or in presence of a target
membrane when that HA is not a member of a fusogenic
aggregate [8,9].
In step 2 of Fig. 1, aggregation is assumed to occur
rapidly compared with subsequent bilayer destabilization,
supported by the analysis in Ref. [10], and remains at
equilibrium. The nucleation mechanism was assumed solely
because it would predict the minimum number of HAs
needed to form a fusion site, not because it is particularly
realistic. This minimal aggregate size is called a fusogenic
aggregate, which has been fitted as xz 8 [10]. Other, more
realistic, distributions would yield larger numbers for the
minimal aggregate size [10,39].
In step 3 of Fig. 1, the HAs within the fusogenic
aggregate independently and identically undergo the essen-
tial conformational change. Once q of them have done so,
then the fusogenic aggregate can form the first fusion pore
(FP), as shown in step 4. Note that while qVx, it is
otherwise independent of x [10]. The first fusion pore is
measured by conductivity [23] or transmembrane electro-
static potential changes [14]. This transforms to a lipid
channel (LC), monitored by the spread of fluorescent lipids
Fig. 1. The comprehensive kinetic model for influenza hemagglutinin mediated membrane fusion. The protonation reactions shown in step 1 are assumed to
occur instantaneously, relative to the protein conformational changes, and remain at equilibrium throughout the fusion process. Stoichiometrically, we are
concerned only about the last protonation site for each of the monomers in the HA trimer. HA trimer in native form (HAna) is protonated to expose the fusion
peptide (HAfp). According to the model proposed in Ref. [8] and extended in Ref. [9], the exposed fusion peptide embeds into the viral membrane (HAem) or is
further protonated to become an inactivable species (HAfi). HAfi can either inactivate directly resulting in HAin (HA incapable of being a part of the fusion
mechanism) or can proceed as a part of HAem species. In principle, all HAin derived from the HAem species should come from HAfi species. Step 2 represents
nucleation aggregation that is at equilibrium, assumed to guarantee the smallest estimate for the number of HAs in a fusogenic aggregate. Following
protonation, the HAem aggregate of size x forms, rapidly denoted as Xx,0. x is the minimal size for a fusogenic aggregate and a lower bound of eight was found
by kinetic analysis in Ref. [10], i.e. xz 8. At step 3, x denotes the number of the HAs within the fusogenic aggregate which can undergo the essential
conformational change, independently and identically with a rate constant of kf. Thus, the overall rate constant for the first reaction would be xkf. These
conformational changes continue for each HA until q of them have occurred, Xx,q. q is called the minimal fusion unit, as it equals the minimum number of HAs
that have undergone the essential conformational change needed to stabilize the first high energy intermediate for fusion. At step 4, the fusogenic aggregate can
transform to the first fusion pore, which is observed as the first conductivity across the apposed membranes. The first fusion pore, FP, evolves to the lipid
channel, LC, demarked by mixing of lipids, which evolves to the fusion site, FS, demarked by aqueous contents mixing.
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formed, as monitored by aqueous contents mixing of fluo-
rescent molecules [14], provided there is not too much
leakage of contents [24,40,75].3. Consensus kinetic parameter estimates
Table 1 shows the collected parameters fitted thus far
[10,21,22,26]. For each data set, we generated all best fits.
The consensus is defined as the subset of values that can fit
all data sets. While it was significant that the three indepen-
dent data sets of HA expressing cells fusing with target
membranes could be explained, i.e. have similar fittedparameters, with a single kinetic model, there remained
two important questions. First, in terms of these key fusion
site architecture parameters, are the results of HA-expressing
cells applicable to the virion fusing with target membranes?
Second, while the kinetic analysis assumed a single homo-
geneous average surface density for each cell line, because of
computational time constraints, the HA-expressing cells
probably have an inhomogeneous distribution of HA surface
densities. The question, then, was whether the key fusion site
architecture parameters would remain largely unchanged
once the distributions were incorporated into the analysis?
Our results showed, for the first time, consensus quan-
titative agreement on the fusion site architecture for the PR8
influenza virus and Japan-influenza HA expressing cell
Table 1
Summary of fitted rate constants for HA fusion
q Fusion
intermediate
Protein,
kf (s
 1)
Fusion pore,
kp (s
 1)
Lipid channel,
kl (s
 1)
2 FP [23] (0.3–2) 10 4 (0.3–7) 10 4 n.d.
LC [13] (4–4.8) 10 3 (4.5–8) 10 4 (3–5) 10 2
LC [14] (4–4.5) 10 2 (0.03–1) 10 4 (2.5–2.6) 10 2
LC [72] 3 5.4 10 3 1.5 10 1
Parameters from exhaustive fitting of different kinetic data on HA mediated
fusion using steps 3 and 4 of the model in Fig. 1. For a minimal aggregate
size of eight HAs (x= 8 [10]), a minimal fusion unit of two HAs ( q= 2) fit
the data of HA-expressing cells (with Japan strain) fusing with (1)
ganglioside containing planar bilayers at 37 jC [23]; (2) erythrocytes at
28–29 jC; and (3) erythrocyte ghosts at 37 jC. The same minimal fusion
unit fit the data of PR/8 strain virions fusing with ganglioside containing
liposomes [72]. See text for details.
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the minimal fusion unit q = 2 are obtained from ratios of
fitted parameters, the effects of the expected distributions of
HA surface densities on the HA-expressing cells are not
very significant. We will discuss this finding in ‘‘Proposed
mechanism of HA-mediated membrane fusion’’.
We found that fitting all the PR/8 viral fusion data
simultaneously and selecting the best-fit parameter sets
yielded only two convergent solutions for parameters [21],
as opposed to ranges for parameters [10,22] because more
curves were being fitted simultaneously. By providing more
data, with less experimental noise, steps 3 and 4 of the
kinetic model in Fig. 1 are able to extract very robust
estimates for the kinetic parameters.
We find that as the experimental systems provide higher
surface density of HAs in the area of contact, the value of
the average rate of the essential conformational change of
HA, kf, increases. As can be seen from Table 1, kf for the
virus is f 3 s 1, which is 1–2 orders of magnitude faster
than HA-expressing cells fusing with RBCs, where surface
density of HA in the area of contact is increased due to
accumulation resulting from HA-glycophorin binding [22].
Blumenthal et al. [14] used 37 jC, as compared to 28–29
jC used by Danieli et al. [13], which explains much of the
difference in the fitted values for kf. The value of kf for the
virus is 4 orders of magnitude faster than HA-expressing
cells fusing with ganglioside containing planar bilayers
[10,22], where very little HA binding and accumulation
occurs.
The increase of kf with HA surface density suggests
cooperativity, which is not yet incorporated into the kinetic
model, since its mechanism is not yet known. An increased
HA surface density should yield more and larger fuso-
genic aggregates [10,39]. Based upon our current knowl-
edge, while more fusogenic aggregates would not promote
any cooperativity, larger aggregates might. Markovic et al.
[38] found that the overall refolding rate of Japan, X-31
and Udorn HA increases with increasing surface density,
as assayed by subsequent DTT dissociation of the HA.
They suggested cooperativity as the mechanism. Theavenue of this cooperativity could well through the fusion
peptides embedded in the viral or HA-expressing cell
bilayers [8].
Both kp and kl are an order of magnitude faster for the
virions fusing with target membranes than what we previ-
ously found for HA-expressing cells fusing with target
membranes. The differences might simply be HA-strain
dependent. Since the liposomes used by Shangguan et al.
[24,25] were similar in composition to the planar bilayer
used by Melikyan et al. [23], the differences are not likely to
be due to target membrane properties. Also, the similarity in
rate constants for lipid mixing and contents mixing found
here for HA mediated fusion and by Lee and Lentz [41] for
PEG-induced fusion of phosphatidylcholine liposomes sup-
ports the idea that subsequent to stable fusion pore forma-
tion, the evolution of fusion intermediates is determined
more by the lipids than by the proteins. This is consistent
with a lipidic stalk being common to bilayer fusion mech-
anisms, see Kozlovsky et al. (2002) [81] for a discussion.
Mittal et al. [21] found a pKa of 5.6–5.7 for activation
both PR8 and Japan strains of HA and a pKi of 4.8–4.9 for
inactivation of HA for the PR/8 strain of HA. This provides
an incentive to investigate key histidine, aspartate or gluta-
mate residues common to all strains. While the pKa of the
histidine side chain is closest to the value we find, glutamate
and aspartate pKs could be increased by hydrophobic or
negatively charged neighbors.
Fitting inactivation data of Leikina et al. [19], Japan HA-
expressing cells and RBC, and Shangguan et al. [25], PR8
virions and 10 mol% ganglioside PC liposomes, both gave
an estimate for the rate constant for inactivation as kfif 2
10 4 s 1 [21]. This is about the same as kff 110 4s 1
measured by Bentz [10] for the data of Melikyan et al. [23],
wherein Japan HA expressing cells fused with ganglioside
containing bilayers. The simplest interpretation of kf and kfi
is that they measure the same event, e.g. formation of the
extended coiled coil, in the presence and absence of a target
membrane, except that kf also refers to a ‘‘successful’’
conformational change, which helps the first fusion pore to
form. We would expect kfi to measure the basal rate for an
unbound and unaggregated HA.4. HA conformations
During infection, virus bound to the cell surface is
endocytosed and exposed to low pH, which produces at
least three new conformations in HA, as depicted in Fig. 2.
The native structure of HA (Fig. 2, conformation 1) is based
upon the crystal structure of the bromelain-released hemag-
glutinin ectodomain, BHA [42]. Upon acidification, expo-
sure of the amino terminus of HA2, known as the fusion
peptide, occurs (Fig. 2, conformation 2). This change is
rapid compared to fusion and is required to promote fusion
between the viral envelope and the target membrane [43–
47,82]. The second conformational change leads to the
Fig. 2. The conformations of HA. (1) This is the native conformation of BHA, adapted from Ref. [42]. The globular HA1 headgroups sit on top of the spike-like
HA2. Regions of a-helix and coiled coil are shown as cylinders. The bottom aggregate of a-helices is the transmembrane domain, striped and denoted TM. (2)
Low pH releases the HA2 N-terminus, also known as the fusion peptide, which is shown here as embedded in the viral envelope, although other states are also
possible. (3) The transition to the extended coiled coil by HA2, causes dissociation of the HA1 headgroups. (4) The helix-turn transition at the base of the
original coiled coil of HA2 found in the crystal structure of TBHA2 [85] is shown. This transition has not yet been proven for membrane-bound HA.
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conformation 3), which was predicted by Carr and Kim
[48], proven for the crystallographic structure of a fragment
of BHA (TBHA2, residues 38–175 of HA2 and 1–27 of
HA1 held together by the disulfide bond) by Bullough et al.
[49] and morphologically observed on the intact virus by
Shangguan et al. [25], as discussed in Bentz [10]. In
addition, Qiao et al. [16] showed that site-directed point
mutations predicted to inhibit the formation of the extended
coiled coil did inhibit the fusion of erythrocytes to HA
expressing cells. This conformational change would extractthe fusion peptide from the viral bilayer and relocates it
more than 10 nm towards the target membrane. New
stretches of coiled coil structure are formed.
The crystal structure of TBHA2 [49] also shows that the
C-terminal end of HA2, where the native coiled coil flares
out to accommodate the fusion peptide in the native state,
flips up in helix turn between residues 106–112 of HA2
and forms an antiparallel a-helical annulus from residues
113–129 of HA2, i.e. at the base of the extended coiled coil
(see Fig. 2, conformation 4). This helix-turn transition has
been proposed as the essential conformational change to
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[1,49–55].
Kim et al. [56] have argued that the helix-turn region,
which they term the kink region of HA2 (aa 105–113), is
important for fusion, while Epand et al. [57] and Leikina et
al. [19] have found that the FHA2 fragment (the equilibrium
structure of aa 1–127 of HA2, which runs from the fusion
peptide to the end of the annular a-helix, with the extended
coiled coil in place and the kink exposed) mediates mem-
brane destabilization and lipid mixing in a pH-dependent
fashion. FHA2 reversibly aggregates at low pH via the kink
region [19,56,58], almost certainly due to hydrophobic
amino acids.5. Proposed mechanism of HA-mediated membrane
fusion
Based upon the fitted kinetic parameters of HA fusion
from a variety of experimental systems, we can construct a
mechanism which is consistent with all of the data exam-
ined. HA contains a sialate binding site within the HA1
subunit that can bind to glycosylated proteins and ganglio-
sides [59]. This provides a wide range of target receptors.
Once bound to the target cell, the influenza virion is
endocytosed. Acidification of the endosome protonates
HA, which is the signal for fusion. This initiates the cascade
of conformational changes leading to merger of the viral and
endosomal membranes. After the signal for fusion, the
fusion peptide is exposed on the N-terminus of these
proteins [52,60–62].
While there has been a long literature proposing that the
exposed N-terminal of HA next inserts into the target
membrane to start fusion, it is more accurate to say that
HAs can have their fusion peptides either suspended between
the membranes or embedded in the target bilayer or in their
own bilayer [4,25,63,64]. The fraction in each state probably
depends upon time and the real question is: Which state or
which sequence of states is on the ‘‘fusion pathway’’?
The common speculation follows from Skehel and Wiley
[1], which had the extended coiled coil bring the fusion
peptide to the target membrane bilayer, to hold the mem-
branes in apposition, presumably about 15 nm apart. The
helix turn then brought the bilayers together [49], stabilized
by the N-cap formation at the C-terminus of the extended
coiled coil [7,51]. This mechanism has been proposed for
HIV fusion also (see [71]). While the N-cap structure is
quite interesting, for it to form in vivo would require the HA
transmembrane domain to dissociate and reform over the N-
terminus of the extended coiled coil. While this is the most
stable form of the EBHA2 fragment in solution, it is unclear
how HA2, with its transmembrane domain embedded in the
viral bilayer, would accommodate, or even get to, this
structure. This model has not yet been used to construct a
pathway by which the lipids of the target bilayer reach the
viral bilayer.Alternatively, Kozlov and Chernomordik [4] and Bentz
[8] have proposed that those HAs whose fusion peptides
embed initially into the viral/HA-expressing cell envelope
are on the fusion pathway. Having the fusion peptide reach
the target membrane represents a later step in the process.
Thus, in Fig. 2 (conformation 2), the fusion peptide is
shown to be embedded in the viral envelope and this is
the population we follow.
The next step is aggregation of the fusion proteins. As
discussed previously, we have shown that rapid aggregation
of eight or more HAs followed by a slow ‘‘essential’’
conformational change of two of the HAs within the
aggregate fitted key kinetic data from different laboratories.
The cause of this rapid HA aggregation is not known. It
could be adhesion of the fusion peptides within the aqueous
space [65], although this would seemingly render the fusion
peptides useless for bilayer destabilization.
Kozlov and Chernomordik [4] have proposed a novel
mechanism for HA aggregation based on membrane curva-
ture minimization. It begins with the fusion peptides em-
bedded in their own (viral or HA-expressing cell) membrane
and under tension created by the formation of the extended
coiled coil. How does a protein create the tension needed to
pull at a membrane, causing it to distort, and thereby induce
HA aggregation, as proposed by Kozlov and Chernomordik
[4]? The formation of the extended coiled coil is simply a
sequence of heptad repeat binding steps, each of which
extends the coiled coil another 10 A˚, or so, and shortens the
line to the fusion peptide by as much as 14 A˚ [9]. The
formation of the next heptad repeat of the extended coiled
coil should proceed by a somewhat random conformational
search, which gets stuck by the formation of heptad repeat.
These proteins proceed down a free energy pathway by
falling through a sequence of quasi-irreversible steps, like a
ratchet. Each step is made essentially irreversible by a large
positive activation energy for return.
According to Kozlov and Chernomordik [4], the heptad
repeat of a single HA has insufficient binding energy to hold
up the bilayer against the curvature energy. However, when
several HAs are close, the net curvature to the bilayer
needed for all of them to sustain one (or more) heptad
repeat binding reactions is sufficiently small to permit the
action. Once a ring of HAs have formed their first heptad
repeats of the extended coiled coil, this holds the bilayer
curvature in place and the aggregate is held in place. Other
HAs can diffuse into the aggregate and form their next
heptad repeat, thereby increasing the tension and the bilayer
curvature. Their model then proposes that the bilayer dome
formed inside the circular HA aggregate is high enough to
contact the target bilayer, where fusion would relieve the
high curvature at the top of the dome.
As discussed in Bentz [8], this model has no role for the
kinetic finding that two of the HAs in the aggregate do
heavy lifting. The dome is formed by the tension formed by
all of the HAs in the aggregate. We have coupled our kinetic
results with the curvature model of Kozlov and Cherno-
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the HA aggregates have 9–12 HAs [39]. Furthermore, the
dome height is at least 4–5 nm from the target bilayer, and
even further is the receptor for HA is a glycoprotein, like
glycophorin. Fig. 3A shows the maximum curvature that
can be induced in the viral membrane as a result of a collar
of nine HA trimers from this calculation, with other HAs in
the aggregate bound to glycophorin receptor. Even if the
target membrane in the area of contact is curved maximally
to approach the curvature of a 30-nm SUV, then also, the
viral membrane curvature is not big enough to introduce
outer monolayer contact. Thus, its seems unlikely that
fusion follows simply by an HA-aggregate-induced bending
of membranes. This is a wide gap for the lipids to cross. It
suggests that there might be more to the mechanism of how
the bilayers start mixing their lipids. This mechanism should
include a role for the two HAs that undergo the slow,
essential conformational change.
Beginning with the model of Kozlov and Chernomordik
[4], there is an appealing segue with the model proposed in
Bentz [8]. With the fusion peptides inserted into the viral
membrane, the HAs will aggregate and begin to form the
dome toward the target membrane. The collar of HAs will
tighten until the site becomes lipid flow restricted, a step
preceding lipid mixing [3,66,67]. Then the dome can grow
no further.
5.1. High-energy conformational change
The question is whether the fusion peptide can remain
embedded until the dome reaches the target membrane.
Kozlov and Chernomordik [4] estimated the energy it takes
to remove an alpha helical hydrophobic peptide from a
bilayer was too great, while recognizing that this is a very
crude calculation, and hypothesize that this membrane
curvature increases until a dome from the viral bilayer
reaches the target membrane. However, as argued in Bentz
[8], there seems to be enough energy in the formation of the
extended coiled coil to extract the HA fusion peptide from
the viral envelope when the molecularity of the site is
considered. For example, within the HA aggregate, theFig. 3. Domes, hydrophobic defects and membrane fusion. (A) A typical
dome created in the viral bilayer by an aggregate of nine HAs was
calculated in Ref. [39], based on the formulations in Ref. [4]. Even for the
maximum achievable curvature in the target membrane, shown by a 30-nm
SUV, the outer monolayers are still substantially separated. Thus,
membrane fusion seems unlikely to be initiated simply by bilayer–bilayer
contact. (B) Extraction of fusion peptides from the viral bilayer creates
hydrophobic defects. (C) The hydrophobic defects percolate to the top of
the dome, thereby reducing the elastic curvature energy, creating a
hydrophobic cavity. The structures in (B) and (C) are stabilized by
transmembrane domains of HA and subsequently, by the low-energy
conformational change exposing the hydrophobic kink region to the defect.
When the hydrophobic defect at the top of the dome is big enough, viral
inner monolayer lipids are engaged [68]. Lipids from the outer monolayer
of the target membrane heal the defect initiating membrane fusion.surface density of fusion peptides is very large and aggre-
gates of fusion peptides could form [83], substantially
reducing the energy needed to extract one of them from
the site. The release of the fusion peptide from the viral
bilayer would likely precipitate the rapid completion of the
extended coiled coil for that HA and the translocation of that
trio of fusion peptides to the target membrane. The HA
transmembrane domains are required to be part of the
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closely packed enough to restrict lipid flow (see Fig. 3
and Ref. [8]). Having the transmembrane domains as part of
the surface of the hydrophobic defect lowers the free energy
required for its creation.
While the formation of the extended coiled coil of HA2
would extract the fusion peptides from the outer monolayer
of the viral envelope, for those HA in isolation or in
aggregates not in the state of restricted lipid flow, the
evacuated space in the viral outer monolayer will be quickly
filled by lipid diffusion. As a result, little or no significant
change will happen on the viral envelope. Later on, for
isolated virions, significant blebbing of the envelopes occurs
[25]. Presumably, the fusion peptides of all the HAs
undergoing the formation of the extended coiled coil would
embed in the target membrane, which would explain the
hydrophobic binding of virions to target membranes, e.g.
liposomes, which occurs before fusion [3,8,10,45,68]. How-
ever, for those fusion peptides embedded initially within the
site of restricted lipid flow (caused by fusogenic aggregate),
the evacuated space cannot be refilled instantly, since the
aggregated HA transmembrane domains and the remaining
embedded fusion peptides would block the flow. Thus, a
hydrophobic defect would be created at the site of extraction
of this fusion peptide (see Fig. 3B), stabilized by the large
aggregate of HAs, like a dam [8].
To probe the meaning of a persistent hydrophobic
defect in a bilayer, Tieleman and Bentz [69] performed
molecular dynamic simulations of up to 10 ns of a planar
PC bilayer from which lipids have been deleted randomly
from one monolayer. In one set of simulations, about half
the lipids in the defect monolayer were restrained to form a
mechanical barrier. In the second set, lipids were free to
diffuse. The question was simply whether the defects in
the monolayer caused by removing lipids (the ones shown
in Fig. 3B left by removing the embedded fusion peptide)
would aggregate together, forming a large hydrophobic
cavity, or whether the membrane would adjust in another
way.
It was found that in the absence of mechanical barriers,
the lipids in the defect monolayer simply spread out and
thinned, with little effect on the other ‘‘intact’’ monolayer. In
the presence of a mechanical barrier, the behavior of the
lipids depends on the size of the defect. When 3 lipids out of
64 were removed, the remaining lipids adjust the lower half
of their chains but the headgroup structure changed little and
the intact monolayer is unaffected. When 6–12 lipids were
removed, the defect monolayer thins, lipid disorder
increases, and lipids from the intact monolayer move
towards the defect monolayer.
Our simulation showed a coupling of the intact mono-
layer with the defect when the defect perimeter lipids were
fixed and six or more lipids were removed. This break point
is interesting since two bilayer-embedded HA fusion pep-
tides would occupy about the same surface area as 6 or so
lipids, so that their removal would create about the same-sized hydrophobic defect. So, in the proposed fusogenic HA
aggregate [8,9], the removal of two embedded fusion
peptides from the center of the fusogenic aggregate would
create a large enough hydrophobic defect to cause the intact
monolayer acyl chains to enter into the defect area of the
defect monolayer because of the hydrophobic transmem-
brane domains.
Provided that the ‘‘dam’’ of HAs remains intact, this
scenario is reasonable and provides a first guess as to the
molecular definition of ‘‘engaging the inner monolayer’’,
which can distinguish between the defects which lead to
fusion from those which lead only to hemifusion. That is,
amphipathic peptides [9,19], low surface densities of HA
[15] and some mutant HAs [5,15–18] only disturb the outer
monolayers, leading to hemifusion. Here we have an exam-
ple of how a hydrophobic defect in the lipid defect mono-
layer, if surrounded by a hydrophobic mechanical barrier,
will engage the inner/intact monolayer.
Clearly, we are a long way from fusion and from
evidence for the formation of a hydrophobic cavity. Obvious
in Fig. 3B is the large distance between the bilayers.
Likewise, these simulations run 10 ns, which leaves a long
time for other events to occur. But it is a beginning. These
simulations assumed a planar bilayer, since the extension to
curved membranes is not yet theoretically feasible. If the
beginning point for the fusogenic aggregate is a lipid dome
tightly ringed by the aggregated HAs, then there is a
positive elastic energy at the peak of the dome, due to its
curvature [4]. One way to minimize the elastic energy of the
curved dome would be to percolate the hydrophobic defects
to its peak, thereby creating a single cavity, which would
ameliorate the curvature free energy with little effect on the
hydrophobic free energy, as shown in Fig. 3C.
5.2. Low-energy conformational change and the hydro-
phobic kink
It has been recently shown that the kink formed by the
helix turn of HA mediates the low pH-dependent aggrega-
tion of the HA fragment known as FHA2, which comprises
amino acids 1–127, i.e. the fusion peptide through the C-
terminus of the six helix bundle at equilibrium [56,58]. This
aggregation appears to be hydrophobically driven, perhaps
following the protonation of aspartates within the kink
region. This same fragment induces hemifusion between
liposomes [57] and between cells [19]. Mutants in the kink
region or lacking the fusion peptide do not induce lipid
mixing.
A useful function of such a hydrophobic kink in fusion is
readily apparent in the model of fusion shown in Fig. 3C.
The formation of one or two helix turns would bend HA,
allowing the close approach of the membranes. Just as
importantly, the hydrophobic kink would now form a
hydrophobic collar just above the hydrophobic defect.
Bilayer lipids making an excursion from the target mem-
brane would be stabilized by this hydrophobic collar and
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hydrophobic defect, i.e. begin lipid mixing. Like an enzyme,
the hydrophobic collar would stabilize the transition state of
fusion.
For the viral fusion proteins using coiled coils and
folding something like HA [1,84], this hydrophobic kink
should be near the C-terminus of the N-heptad repeat region
or near the N-terminus of the C-heptad repeat region.
Interestingly, Peisajovich et al. [70] have claimed to find a
‘‘second fusion peptide’’ in the Sendai virus F1 protein near
the C-terminus of the N-heptad repeat domain.
It has been shown that the helix turn of HA [7] and its
presumed equivalent in HIV [2,71] are required for fusion.
All of the models that propose that the formation of the
extended coiled coil simply tethers the membranes together
predict that the helix turn is also required for fusion [1,2]. In
fact, this is what the model of Fig. 3 would predict for HA,
as explained in detail in Ref. [8]. Our hypothesis is also
explicitly two-step, wherein a high-energy conformational
change creates the defect and a low-energy conformational
change is required to communicate that defect to the target
membrane. If either step is blocked, then fusion is blocked.
If the target bilayer is too far from the hydrophobic defect,
then eventually the aggregate will disperse as the remaining
HAs undergo the essential conformational change and lipid
lateral diffusion fills the defect region [8]. As stated at the
beginning, the question of whether bilayer fusion initiates
with the contact of the dome with the target bilayer or with a
HA aggregate stabilized hydrophobic defect providing a
sink for lipids permeating from the target bilayer has not yet
been answered. We believe that the consequences of both
models must be compared with the detailed kinetics of
fusion before clarifying experiments will emerge.References
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